Vista Current Coverage

All Johnson & Johnson Articles

J&J Accelerates Quarterly Profits

Recently, Johnson & Johnson (JNJ) announced that their Q1 earnings which exceeded market expectations. The company highlighted how their drug Stelara, used for the treatment of psoriasis and Crohn’s disease, enjoyed a double-digit increase of about 32% bringing it to  $1.41 billion & now is...

J&J Announces Q1 2019 Dividend

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson started the New Year off by announcing that its Board of Directors...

J&J Shares Plummeted With Report of Asbestos in Baby Powder

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson saw its shares drop 10 percent on Friday, the most they’ve dropped...